Great Lakes Advisors LLC Makes New $1.43 Million Investment in Danaher Corporation $DHR

Great Lakes Advisors LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 7,498 shares of the conglomerate’s stock, valued at approximately $1,428,000.

Other hedge funds have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in Danaher during the 2nd quarter valued at $10,492,520,000. State Street Corp boosted its stake in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors lifted its holdings in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares during the period. Finally, Wellington Management Group LLP boosted its position in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after acquiring an additional 1,517,904 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $219.42 on Friday. The firm has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The business has a fifty day moving average of $195.80 and a 200 day moving average of $192.61.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 EPS. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on DHR. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Wells Fargo & Company reduced their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Citigroup started coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Evercore reiterated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Finally, HSBC lowered their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.